These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 28494795

  • 21. An effective intervention to reduce intravaginal practices among HIV-1 uninfected Kenyan women.
    Sivapalasingam S, McClelland RS, Ravel J, Ahmed A, Cleland CM, Gajer P, Mwamzaka M, Marshed F, Shafi J, Masese L, Fajans M, Anderson ME, Jaoko W, Kurth AE.
    AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1046-54. PubMed ID: 25265254
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of bacterial vaginosis and associated risk factors in pregnant women receiving antenatal care at the Kumba Health District (KHD), Cameroon.
    Kamga YM, Ngunde JP, Akoachere JKT.
    BMC Pregnancy Childbirth; 2019 May 10; 19(1):166. PubMed ID: 31077161
    [Abstract] [Full Text] [Related]

  • 23. Women view key sexual behaviours as the trigger for the onset and recurrence of bacterial vaginosis.
    Bilardi JE, Walker SM, Temple-Smith MJ, McNair RP, Mooney-Somers J, Vodstrcil LA, Bellhouse CE, Fairley CK, Bradshaw CS.
    PLoS One; 2017 May 10; 12(3):e0173637. PubMed ID: 28278277
    [Abstract] [Full Text] [Related]

  • 24. The effect of vaginal douching cessation on bacterial vaginosis: a pilot study.
    Brotman RM, Ghanem KG, Klebanoff MA, Taha TE, Scharfstein DO, Zenilman JM.
    Am J Obstet Gynecol; 2008 Jun 10; 198(6):628.e1-7. PubMed ID: 18295180
    [Abstract] [Full Text] [Related]

  • 25. Use of a lactic acid plus lactoserum intimate liquid soap for external hygiene in the prevention of bacterial vaginosis recurrence after metronidazole oral treatment.
    Bahamondes MV, Portugal PM, Brolazo EM, Simões JA, Bahamondes L.
    Rev Assoc Med Bras (1992); 2011 Jun 10; 57(4):415-20. PubMed ID: 21876923
    [Abstract] [Full Text] [Related]

  • 26. A Syndemic Approach to Explore Factors Associated with Bacterial Vaginosis.
    Salazar AS, Nogueira NF, Rodriguez VJ, Mantero A, Cherenack EM, Raccamarich P, Maddalon M, Brophy T, Montgomerie E, Klatt NR, Jones DL, Alcaide ML.
    AIDS Behav; 2022 Sep 10; 26(9):3110-3118. PubMed ID: 35362906
    [Abstract] [Full Text] [Related]

  • 27. Women's Views and Experiences of the Triggers for Onset of Bacterial Vaginosis and Exacerbating Factors Associated with Recurrence.
    Bilardi J, Walker S, Mooney-Somers J, Temple-Smith M, McNair R, Bellhouse C, Fairley C, Chen M, Bradshaw C.
    PLoS One; 2016 Sep 10; 11(3):e0150272. PubMed ID: 26930414
    [Abstract] [Full Text] [Related]

  • 28. Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples - A pilot study.
    Plummer EL, Vodstrcil LA, Danielewski JA, Murray GL, Fairley CK, Garland SM, Hocking JS, Tabrizi SN, Bradshaw CS.
    PLoS One; 2018 Sep 10; 13(1):e0190199. PubMed ID: 29293559
    [Abstract] [Full Text] [Related]

  • 29. Associations between intravaginal practices and bacterial vaginosis in Kenyan female sex workers without symptoms of vaginal infections.
    Hassan WM, Lavreys L, Chohan V, Richardson BA, Mandaliya K, Ndinya-Achola JO, Kiarie J, Jaoko W, Holmes KK, McClelland RS.
    Sex Transm Dis; 2007 Jun 10; 34(6):384-8. PubMed ID: 17065846
    [Abstract] [Full Text] [Related]

  • 30. Cessation of intravaginal practices to prevent bacterial vaginosis: a pilot intervention in Zimbabwean women.
    Esber A, Moyo P, Munjoma M, Francis S, van de Wijgert J, Chipato T, Turner AN.
    Sex Transm Infect; 2015 May 10; 91(3):183-8. PubMed ID: 25355772
    [Abstract] [Full Text] [Related]

  • 31. Distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South African women.
    Myer L, Denny L, de Souza M, Wright TC, Kuhn L.
    Am J Epidemiol; 2006 Mar 15; 163(6):552-60. PubMed ID: 16443804
    [Abstract] [Full Text] [Related]

  • 32. Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms.
    Myer L, Kuhn L, Stein ZA, Wright TC, Denny L.
    Lancet Infect Dis; 2005 Dec 15; 5(12):786-94. PubMed ID: 16310150
    [Abstract] [Full Text] [Related]

  • 33. Prevalence and risks for bacterial vaginosis in women who have sex with women.
    Marrazzo JM, Thomas KK, Agnew K, Ringwood K.
    Sex Transm Dis; 2010 May 15; 37(5):335-9. PubMed ID: 20429087
    [Abstract] [Full Text] [Related]

  • 34. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A, Fitzgerald L, Fiya V, Aeno H, Kelly A, Sauk J, Kupul M, Neo J, Millan J, Siba P, Kaldor JM.
    BMC Res Notes; 2012 Nov 01; 5():613. PubMed ID: 23116431
    [Abstract] [Full Text] [Related]

  • 35. Intravaginal practices, bacterial vaginosis, and HIV infection in women: individual participant data meta-analysis.
    Low N, Chersich MF, Schmidlin K, Egger M, Francis SC, van de Wijgert JH, Hayes RJ, Baeten JM, Brown J, Delany-Moretlwe S, Kaul R, McGrath N, Morrison C, Myer L, Temmerman M, van der Straten A, Watson-Jones D, Zwahlen M, Hilber AM.
    PLoS Med; 2011 Feb 15; 8(2):e1000416. PubMed ID: 21358808
    [Abstract] [Full Text] [Related]

  • 36. Vaginal practices among women at high risk of HIV infection in Uganda and Tanzania: recorded behaviour from a daily pictorial diary.
    Francis SC, Baisley K, Lees SS, Andrew B, Zalwango F, Seeley J, Vandepitte J, Ao TT, van de Wijgert J, Watson-Jones D, Kapiga S, Grosskurth H, Hayes RJ.
    PLoS One; 2013 Feb 15; 8(3):e59085. PubMed ID: 23555618
    [Abstract] [Full Text] [Related]

  • 37. Intravaginal practices and risk of bacterial vaginosis and candidiasis infection among a cohort of women in the United States.
    Brown JM, Hess KL, Brown S, Murphy C, Waldman AL, Hezareh M.
    Obstet Gynecol; 2013 Apr 15; 121(4):773-780. PubMed ID: 23635677
    [Abstract] [Full Text] [Related]

  • 38. Personal hygienic behaviors and bacterial vaginosis.
    Klebanoff MA, Nansel TR, Brotman RM, Zhang J, Yu KF, Schwebke JR, Andrews WW.
    Sex Transm Dis; 2010 Feb 15; 37(2):94-9. PubMed ID: 19823112
    [Abstract] [Full Text] [Related]

  • 39. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health.
    Koumans EH, Sternberg M, Bruce C, McQuillan G, Kendrick J, Sutton M, Markowitz LE.
    Sex Transm Dis; 2007 Nov 15; 34(11):864-9. PubMed ID: 17621244
    [Abstract] [Full Text] [Related]

  • 40. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU, Singh R, Mitchev N, Mlisana K, Jaspan HB, Barnabas SL, Passmore JS.
    BMC Infect Dis; 2020 Jul 10; 20(1):491. PubMed ID: 32650729
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.